Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...

Biotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 ...

Spanish biotech Integra Therapeutics has upped its arsenal of gene editing tools by licensing Caszyme’s Cas12I nucleases, the ...

When tested in mice, the compound—named BBI-2779—shrank gastric tumors and prevented the cancer from developing resistance to ...

A Cathie Wood ARK Invest ETF owns over $46 million of this biotech stock. The stock is climbing ahead of its earnings report.

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

DNA editing makes permanent changes to a person’s genome ... RNA editing is in its nascent stage, yet there are already at ...

If left unchecked, insect pests can devastate crops. To minimize damage and reduce the need for insecticide sprays, crops ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...